Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
More than 2 million people use Erowid every month...
but only 100 of those contribute financially.
If you use Erowid, PLEASE DONATE!
4-Acetoxy-DiPT
Legal Status
by Erowid
U.S. FEDERAL LAW #
Caution :   All legal information should be verified through other sources. [see below]
U.S. FEDERAL LEGAL SUMMARY
4-Acetoxy-DiPT
REGULATED
No
STATUS
Not Approved For
Human Consumption
SCHEDULE
Un-Scheduled
4-Acetoxy-DiPT and 4-HO-DiPT are both uncontrolled substances in the U.S. as well as in most if not all other countries. It could conceivably be covered under the U.S. Analogue Act depending on how it's sold, but there have been no cases brought to trial that we are aware of. (1/Nov/2004)

There are pending cases (beginning July 2004) in which vendors selling 4-Acetoxy-DIPT and other psychoactive chemicals to the general public are being prosecuted. Please see Research Chemical Arrests and Investigations. It is important to note, however, that there have been no convictions in these cases and so there is no further clarification of the legal status of 4-Acetoxy-DIPT at this time.

INTERNATIONAL LAW #
Japan #
4-AcO-DIPT is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell (see Ref)
Sweden #
AMT,2C-C,2C-D, 4-AcO-DIPT, and 4-HO-DIPT were controlled as of March 1, 2005. See Statens Folkhaelsoinstitut. (thanks P)
If you have information about the legal status of this substance in any other country, please let us know.

CAUTION & DISCLAIMER #
Erowid legal information is a summary of data gathered from site visitors, government documents, websites, and other resources. We are not lawyers and can not guarantee the accuracy of the information provided here. We do our best to keep this information correct and up-to-date, but laws are complex and constantly changing. Laws may also vary from one jurisdiction to another (county, state, country, etc)...this list is not comprehensive.